Endocan Corp Stock Revenue
| ENDO Stock | USD 0.0001 0.00 0.00% |
Endocan Corp fundamentals help investors to digest information that contributes to Endocan Corp's financial success or failures. It also enables traders to predict the movement of Endocan Pink Sheet. The fundamental analysis module provides a way to measure Endocan Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Endocan Corp pink sheet.
Endocan |
Endocan Corp Company Revenue Analysis
Endocan Corp's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Endocan Corp reported 0.0 of revenue. This is 100.0% lower than that of the Basic Materials sector and 100.0% lower than that of the Specialty Chemicals industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Endocan Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Endocan Corp's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Endocan Corp could also be used in its relative valuation, which is a method of valuing Endocan Corp by comparing valuation metrics of similar companies.Endocan Corp is currently under evaluation in revenue category among its peers.
Endocan Fundamentals
| Current Valuation | 1.87 M | |||
| Shares Outstanding | 67.89 M | |||
| Price To Earning | (0.09) X | |||
| Price To Book | 18.51 X | |||
| Net Income | (3.31 M) | |||
| Cash And Equivalents | 59 | |||
| Total Debt | 954.59 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (105.94 K) | |||
| Earnings Per Share | (0.12) X | |||
| Number Of Employees | 31 | |||
| Beta | 2.53 | |||
| Market Capitalization | 1.6 M | |||
| Total Asset | 359 | |||
| Retained Earnings | (32.94 M) | |||
| Working Capital | (1.49 M) | |||
| Current Liabilities | 1.49 M | |||
| Net Asset | 359 |
About Endocan Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Endocan Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Endocan Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Endocan Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Endocan Pink Sheet
Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.